Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name CUDC-907
Trade Name
Synonyms Fimepinostat
Drug Descriptions

CUDC-907 (fimepinostat) is a dual PI3K and HDAC inhibitor, which prevents activation of the PI3K-AKT-mTOR signal transduction pathway, inhibits tumor cell growth, and promotes apoptosis in cancer cells (PMID: 22693356, PMID: 32459381).

DrugClasses HDAC Inhibitor 45 PI3K Inhibitor (Pan) 42
CAS Registry Number 1339928-25-4
NCIT ID C104008

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AZD1480 + CUDC-907 AZD1480 CUDC-907 1 0
Bendamustine + CUDC-907 + Rituximab Bendamustine CUDC-907 Rituximab 0 1
CUDC-907 CUDC-907 5 6
CUDC-907 + Gilteritinib CUDC-907 Gilteritinib 1 0
CUDC-907 + Rituximab CUDC-907 Rituximab 0 1
CUDC-907 + Venetoclax CUDC-907 Venetoclax 0 1


Additional content available in CKB BOOST